Importer of Controlled Substances Application: Chattem Chemicals, 71925-71926 [2024-19789]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–1632, 1634,
1635, and 1639 (Final)]
Mattresses From India, Kosovo,
Mexico, and Spain; Determinations
ddrumheller on DSK120RN23PROD with NOTICES1
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that an industry in the United States is
materially injured by reason of imports
of mattresses from India, Kosovo,
Mexico, and Spain, provided for in
subheadings 9404.21.00, 9404.29.10,
and 9404.29.90 of the Harmonized Tariff
Schedule of the United States, that have
been found by the U.S. Department of
Commerce (‘‘Commerce’’) to be sold in
the United States at less than fair value
(‘‘LTFV’’).2
Background
The Commission instituted these
investigations effective July 28, 2023,
following receipt of petitions filed with
the Commission and Commerce by
Brooklyn Bedding LLC, Phoenix,
Arizona; Carpenter Company,
Richmond, Virginia; Corsicana Mattress
Company, Dallas, Texas; Future Foam,
Inc., Council Bluffs, Iowa; FXI, Inc.,
Radnor, Pennsylvania; Kolcraft
Enterprises, Inc., Chicago, Illinois;
Leggett & Platt, Incorporated, Carthage,
Missouri; Serta Simmons Bedding, Inc.,
Doraville, Georgia; Southerland Inc.,
Antioch, Tennessee; Tempur Sealy
International, Inc., Lexington, Kentucky;
the International Brotherhood of
Teamsters, Washington, DC; and the
United Steel, Paper and Forestry,
Rubber, Manufacturing, Energy, Allied
Industrial and Service Workers
International Union, AFL–CIO,
Washington, DC. The Commission
scheduled the final phase of the
investigations following notification of
preliminary determinations by
Commerce that imports of mattresses
from Bosnia and Herzegovina, Bulgaria,
Burma, India, Italy, Kosovo, Mexico,
Philippines, Poland, Slovenia, Spain,
and Taiwan were being sold at LTFV
within the meaning of § 733(b) of the
Act (19 U.S.C. 1673b(b)). Notice of the
scheduling of the final phase of the
Commission’s investigations and of a
public hearing to be held in connection
therewith was given by posting copies
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 89 FR 59047 (India), 89 FR 59043 (Kosovo), 89
FR 59062 (Mexico), and 89 FR 59059 (Spain), July
22, 2024.
VerDate Sep<11>2014
21:26 Sep 03, 2024
Jkt 262001
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register of March 6, 2024 (89 FR
16026). The Commission conducted its
hearing on May 9, 2024. All persons
who requested the opportunity were
permitted to participate.
Although the antidumping duty
petitions for mattresses from Bosnia and
Herzegovina, Bulgaria, Burma, India,
Italy, Kosovo, Mexico, Philippines,
Poland, Slovenia, Spain, and Taiwan
were filed on the same day, July 28,
2023, the investigation schedules
became staggered when Commerce did
not align its investigations concerning
Bosnia and Herzegovina, Bulgaria,
Burma, Italy, Philippines, Poland,
Slovenia, and Taiwan with its
investigations concerning India, Kosovo,
Mexico, and Spain. On June 28, 2024,
the Commission issued final affirmative
determinations in its antidumping duty
investigations of mattresses from Bosnia
and Herzegovina, Bulgaria, Burma, Italy,
Philippines, Poland, Slovenia, and
Taiwan (89 FR 55657, July 5, 2024).
Following notification of final
determinations by Commerce that
imports of mattresses from India,
Kosovo, Mexico, and Spain were being
sold at LTFV within the meaning of
section 735(a) of the Act (19 U.S.C.
1673d(a)), notice of the supplemental
scheduling of the final phase of the
Commission’s antidumping duty
investigations concerning India, Kosovo,
Mexico, and Spain was given by posting
copies of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register (89 FR 60658, July 26, 2024).3
The Commission made these
determinations pursuant to § 735(b) of
the Act (19 U.S.C. 1673d(b)). It
completed and filed its determinations
in these investigations on August 28,
2024. The views of the Commission are
contained in USITC Publication 5539
(August 2024), entitled Mattresses from
India, Kosovo, Mexico, and Spain:
Investigation Nos. 731–TA–1632, 1634,
1635, and 1639 (Final).
By order of the Commission.
3 A countervailing duty petition on mattresses
from Indonesia was also filed on the same day as
the antidumping duty petitions concerning
mattresses from Bosnia and Herzegovina, Bulgaria,
Burma, India, Italy, Kosovo, Mexico, Philippines,
Poland, Slovenia, Spain, and Taiwan. However,
Commerce published a final negative countervailing
duty determination with respect to mattresses from
Indonesia on July 22, 2024 (89 FR 59050). The
Commission therefore terminated its countervailing
duty investigation on mattresses from Indonesia (89
FR 60661, July 26, 2024).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
71925
Issued: August 28, 2024.
Sharon Bellamy,
Supervisory Hearings and Information
Officer.
[FR Doc. 2024–19781 Filed 9–3–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1412]
Importer of Controlled Substances
Application: Chattem Chemicals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chattem Chemicals has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 4, 2024. Such
persons may also file a written request
for a hearing on the application on or
before October 4, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUMMARY:
E:\FR\FM\04SEN1.SGM
04SEN1
71926
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 / Notices
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 19, 2024, Chattem
SUPPLEMENTARY INFORMATION:
Chemicals, 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409–1237,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled substance
Drug code
Methamphetamine .........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ...................................................................................................................
Phenylacetone ...............................................................................................................................................................
Cocaine ..........................................................................................................................................................................
Poppy Straw Concentrate ..............................................................................................................................................
Tapentadol .....................................................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate of
Tapentadol (9780), to bulk manufacture
Tapentadol for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–19789 Filed 9–3–24; 8:45 am]
BILLING CODE P
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 22, 2024, Bright
Green Corporation, 1033 George Hanosh
Boulevard, Grants, New Mexico 87020,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Drug Enforcement Administration
[Docket No. DEA–1415]
Bulk Manufacturer of Controlled
Substances Application: Bright Green
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Bright Green Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 4, 2024. Such
persons may also file a written request
for a hearing on the application on or
before November 4, 2024.
SUMMARY:
Drug code
Marihuana Extract ..........................................................................................................................................................
Marihuana ......................................................................................................................................................................
Tetrahydrocannabinols ..................................................................................................................................................
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–19777 Filed 9–3–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
Drug Enforcement Administration
[Docket No. DEA–1401]
Bulk Manufacturer of Controlled
Substances Application: Continuus
Pharmaceuticals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
VerDate Sep<11>2014
21:26 Sep 03, 2024
Jkt 262001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
I
I
I
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 4, 2024. Such
persons may also file a written request
for a hearing on the application on or
before November 4, 2024.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
ADDRESSES:
Continuus Pharmaceuticals
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
SUMMARY:
7350
7360
7370
Schedule
DATES:
DEPARTMENT OF JUSTICE
AGENCY:
BILLING CODE 4410–09–P
II
II
II
II
II
II
ADDRESSES:
DEPARTMENT OF JUSTICE
Controlled substance
The company plans to bulk
manufacture the listed controlled
substances for research purposes. No
other activities for these drug codes are
authorized for this registration.
1105
8333
8501
9041
9670
9780
Schedule
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 89, Number 171 (Wednesday, September 4, 2024)]
[Notices]
[Pages 71925-71926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19789]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1412]
Importer of Controlled Substances Application: Chattem Chemicals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chattem Chemicals has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 4, 2024. Such persons may also file a written request for a
hearing on the application on or before October 4, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
[[Page 71926]]
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 19, 2024, Chattem Chemicals, 3801 Saint Elmo
Avenue, Chattanooga, Tennessee 37409-1237, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine..................... 1105 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone....................... 8501 II
Cocaine............................. 9041 II
Poppy Straw Concentrate............. 9670 II
Tapentadol.......................... 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers. The
company plans to import an intermediate of Tapentadol (9780), to bulk
manufacture Tapentadol for distribution to its customers. No other
activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-19789 Filed 9-3-24; 8:45 am]
BILLING CODE P
